# Transcriptomic Analysis of Differentially Expressed Genes in Type 2 Diabetes Using RNA-Seq Data

**Author:** Bhavika Pawar  
**Organization:** Bversity Bioinfo PG Diploma Program  
**Pipeline Environment:** Google Colab (Python 3 Runtime)  

---

## 1. Abstract

* **Background:** Type 2 Diabetes (T2D) is a complex metabolic disorder marked by progressive pancreatic beta-cell dysfunction and insulin resistance. High-throughput transcriptomics offers a systematic approach to decode the underlying regulatory changes driving this pathology.
* **Objective:** This project aims to design and implement a computational pipeline to identify differentially expressed genes (DEGs) that serve as high-confidence diagnostic biomarkers or therapeutic targets for T2D.
* **Methods:** Using an optimized bioinformatics workflow in Python, a structural expression matrix was filtered for low-abundance counts, log-normalized ($\log_2(\text{Counts} + 1)$), and screened for statistical variations using an independent two-sample $t$-test ($|\log_2\text{FC}| > 0.5$, $p < 0.05$).
* **Results:** Out of 1,000 evaluated genetic features, 34 genes were isolated as highly significant DEGs. Specifically, **21 genes were significantly upregulated** and **13 genes were significantly downregulated** in the Type 2 Diabetes cohort compared to healthy controls.
* **Conclusion:** The isolated expression patterns successfully clustered the clinical groups, providing key molecular signatures that bridge raw sequence processing with downstream clinical application and translational research.

---

## 2. Introduction

* **Background:** Type 2 Diabetes (T2D) constitutes one of the most pressing global health challenges of the 21st century. Characterized by systemic disruptions in glucose metabolism, its clinical hallmarks include a defective insulin response in peripheral tissues alongside an ultimate failure of pancreatic beta-cells to secrete adequate insulin levels. 
* **Problem Statement:** Although the macroeconomic risk factors of diabetes are thoroughly categorized, the precise cellular pathways triggering initial transcriptomic rewiring remain elusive. Traditional genomic screenings often fail to isolate fine-grain, state-specific gene switches due to sequencing noise and baseline scaling differences across raw sample sets.
* **Objectives:** The core target of this project is to implement a robust, reproducible exploratory workflow capable of resolving these differences. By systematically isolating significantly altered transcript structures, we aim to map out disease-specific biomarkers that can be directly leveraged by industrial R&D teams for targeted drug discovery and personalized molecular diagnostics.

---

## 3. Materials and Methods

### Data Sources
The dataset utilizes a structural RNA-Seq expression matrix comprising 1,000 genomic features across 10 distinct biological profiles: 5 Non-Diabetic Controls and 5 confirmed Type 2 Diabetes donor samples. 

### Tools and Software
* **Programming Environment:** Google Colab (Python 3 Runtime environment)
* **Core Packages:** `Pandas` (v2.2) and `NumPy` (v2.0) for array data matrix manipulation
* **Statistical Logic:** `SciPy.stats` module for parametric hypothesis evaluation
* **Visualization Engine:** `Matplotlib` and `Seaborn` for publishing high-resolution graphics

### Pipeline / Workflow Flowchart
```text
[Raw Count Input Matrix] 
         │
         ▼
[Low-Abundance Filtering] ──► Removes genes with < 10 total reads
         │
         ▼
[Log2 Normalization]      ──► Formulates log2(Counts + 1) to stabilize variance
         │
         ▼
[Two-Sample t-test]       ──► Computes Fold Change and parametric p-values
         │
         ▼
[Threshold Slicing]       ──► Categorizes features into Upregulated/Downregulated/NS
         │
         ▼
[Downstream Visuals]      ──► Outputs final Volcano Plots and Clustered Heatmaps
